Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dominik Fischer, who completed his DPhil in our Department, received an extraordinary professorship at the Eberhard Karls University of Tübingen on Tuesday 7 July 2015.

In this clinical academic position, he will continue his work on retinal gene therapy at the Centre for Ophthalmology, Tübingen.

Dominik has been involved in pre-clinical and clinical gene therapy programmes in Professor Robert MacLaren’s group as MRC Clinical Research Training Fellow since 2012.

Professor Dominik Fischer is principal investigator of the first clinical retinal gene therapy trials in Germany with his team at the Universty Eye Hospital Tübingen.

Similar stories

NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills

Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.

How to use the science of the body clock to improve our sleep and health

Professor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.

Obituary: Carol Holder

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

How our dreams changed during the COVID-19 pandemic

This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.